G to A hypermutation of TT virus

Virus Research

Volumn 149, Issue 2, 2010, Pages 211-216

  Tsuge, Masataka ^a,b   Noguchi, Chiemi ^a,b   Akiyama, Rie ^a,b   Matsushita, Miyuki ^a,b   Kunihiro, Kana ^a,b   Tanaka, Sachi ^a,b   Abe, Hiromi ^a,b   Mitsui, Fukiko ^a,b   Kitamura, Shosuke ^a,b   Hatakeyama, Tsuyoshi ^a,b   Kimura, Takashi ^a,b   Miki, Daiki ^a,b   Hiraga, Nobuhiko ^a,b   Imamura, Michio ^a,b   Takahashi, Shoichi ^a,b   Hayses, C Nelson ^a,b   Chayama, Kazuaki ^a,b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

3D PCR; APOBEC; HBV; Hypermutation; TTV

Indexed keywords

ADENINE; ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN B EDITING COMPONENT 3; CYTIDINE DEAMINASE; GUANINE; UNCLASSIFIED DRUG; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENOME HYPERMUTATION; HEPATITIS B VIRUS; HUMAN; MALE; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TORQUE TENO VIRUS; VIRUS CARRIER; VIRUS GENOME;

ADULT; BLOOD; CYTOSINE DEAMINASE; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; TORQUE TENO VIRUS;

HEPATITIS B VIRUS; TORQUE TENO VIRUS;

EID: 77950629079     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.01.019     Document Type: Article

References (32)

1. Ball J.K., Curran R., Berridge S., Grabowska A.M., Jameson C.L., Thomson B.J., Irving W.L., Sharp P.M. TT virus sequence heterogeneity in vivo: evidence for co-infection with multiple genetic types. J. Gen. Virol. 1999, 80(Pt 7):1759-1768.
2. Bishop K.N., Holmes R.K., Malim M.H. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination. J. Virol. 2006, 80(17):8450-8458.
3. Bishop K.N., Holmes R.K., Sheehy A.M., Malim M.H. APOBEC-mediated editing of viral RNA. Science 2004, 305(5684):645.
4. Bonvin M., Achermann F., Greeve I., Stroka D., Keogh A., Inderbitzin D., Candinas D., Sommer P., Wain-Hobson S., Vartanian J.P., Greeve J. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 2006, 43(6):1364-1374.
5. Chayama K., Kobayashi M., Tsubota A., Kobayashi M., Arase Y., Suzuki Y., Saitoh S., Murashima N., Ikeda K., Okamoto K., Hashimoto M., Matsuda M., Koike H., Kobayashi M., Kumada H. Susceptibility of TT virus to interferon therapy. J. Gen. Virol. 1999, 80(Pt 3):631-634.
6. Chen H., Lilley C.E., Yu Q., Lee D.V., Chou J., Narvaiza I., Landau N.R., Weitzman M.D. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Curr. Biol. 2006, 16(5):480-485.
7. Chen K., Huang J., Zhang C., Huang S., Nunnari G., Wang F.X., Tong X., Gao L., Nikisher K., Zhang H. Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells. J. Virol. 2006, 80(15):7645-7657.
8. Conticello S.G., Langlois M.A., Yang Z., Neuberger M.S. DNA deamination in immunity: AID in the context of its APOBEC relatives. Adv. Immunol. 2007, 94:37-73.
9. Delebecque F., Suspene R., Calattini S., Casartelli N., Saib A., Froment A., Wain-Hobson S., Gessain A., Vartanian J.P., Schwartz O. Restriction of foamy viruses by APOBEC cytidine deaminases. J. Virol. 2006, 80(2):605-614.
10. Ganem D. Virology. The X files-one step closer to closure. Science 2001, 294(5550):2299-2300.
11. Harris R.S., Bishop K.N., Sheehy A.M., Craig H.M., Petersen-Mahrt S.K., Watt I.N., Neuberger M.S., Malim M.H. DNA deamination mediates innate immunity to retroviral infection. Cell 2003, 113(6):803-809.
12. Hino S. TTV, a new human virus with single stranded circular DNA genome. Rev. Med. Virol. 2002, 12(3):151-158.
13. Kao J.H., Chen W., Chen P.J., Lai M.Y., Chen D.S. TT virus infection in patients with chronic hepatitis B or C: influence on clinical, histological and virological features. J. Med. Virol. 2000, 60(4):387-392.
14. Kijak G.H., Janini M., Tovanabutra S., Sanders-Buell E.E., Birx D.L., Robb M.L., Michael N.L., McCutchan F.E. HyperPack: a software package for the study of levels, contexts, and patterns of APOBEC-mediated hypermutation in HIV. AIDS Res. Hum. Retroviruses 2007, 23(4):554-557.
15. Lecossier D., Bouchonnet F., Clavel F., Hance A.J. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 2003, 300(5622):1112.
16. Lochelt M., Romen F., Bastone P., Muckenfuss H., Kirchner N., Kim Y.B., Truyen U., Rosler U., Battenberg M., Saib A., Flory E., Cichutek K., Munk C. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(22):7982-7987.
17. Maggi F., Tempestini E., Lanini L., Andreoli E., Fornai C., Giannecchini S., Vatteroni M., Pistello M., Marchi S., Ciccorossi P., Specter S., Bendinelli M. Blood levels of TT virus following immune stimulation with influenza or hepatitis B vaccine. J. Med. Virol. 2005, 75(2):358-365.
18. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424(6944):99-103.
19. Mariani R., Chen D., Schrofelbauer B., Navarro F., Konig R., Bollman B., Munk C., Nymark-McMahon H., Landau N.R. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003, 114(1):21-31.
20. Nishizawa T., Okamoto H., Konishi K., Yoshizawa H., Miyakawa Y., Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys. Res. Commun. 1997, 241(1):92-97.
21. Noguchi C., Hiraga N., Mori N., Tsuge M., Imamura M., Takahashi S., Fujimoto Y., Ochi H., Abe H., Maekawa T., Yatsuji H., Shirakawa K., Takaori-Kondo A., Chayama K. Dual effect of APOBEC3G on hepatitis B virus. J. Gen. Virol. 2007, 88(Pt 2):432-440.
22. Noguchi C., Imamura M., Tsuge M., Hiraga N., Mori N., Miki D., Kimura T., Takahashi S., Fujimoto Y., Ochi H., Abe H., Maekawa T., Tateno C., Yoshizato K., Chayama K. G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection. J. Infect. Dis. 2009, 199(11):1599-1607.
23. Noguchi C., Ishino H., Tsuge M., Fujimoto Y., Imamura M., Takahashi S., Chayama K. G to A hypermutation of hepatitis B virus. Hepatology 2005, 41(3):626-633.
24. Norder H., Courouce A.M., Magnius L.O. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 1994, 198(2):489-503.
25. Peng G., Lei K.J., Jin W., Greenwell-Wild T., Wahl S.M. Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity. J. Exp. Med. 2006, 203(1):41-46.
26. Rosler C., Kock J., Kann M., Malim M.H., Blum H.E., Baumert T.F., von Weizsacker F. APOBEC-mediated interference with hepadnavirus production. Hepatology 2005, 42(2):301-309.
27. Russell R.A., Wiegand H.L., Moore M.D., Schafer A., McClure M.O., Cullen B.R. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J. Virol. 2005, 79(14):8724-8731.
28. Suspene R., Guetard D., Henry M., Sommer P., Wain-Hobson S., Vartanian J.P. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(23):8321-8326.
29. Suspene R., Henry M., Guillot S., Wain-Hobson S., Vartanian J.P. Recovery of APOBEC3-edited human immunodeficiency virus G→A hypermutants by differential DNA denaturation PCR. J. Gen. Virol. 2005, 86(Pt 1):125-129.
30. Suspene R., Sommer P., Henry M., Ferris S., Guetard D., Pochet S., Chester A., Navaratnam N., Wain-Hobson S., Vartanian J.P. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase. Nucleic Acids Res. 2004, 32(8):2421-2429.
31. Tanaka Y., Marusawa H., Seno H., Matsumoto Y., Ueda Y., Kodama Y., Endo Y., Yamauchi J., Matsumoto T., Takaori-Kondo A., Ikai I., Chiba T. Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. Biochem. Biophys. Res. Commun. 2006, 341(2):314-319.
32. Zhang H., Yang B., Pomerantz R.J., Zhang C., Arunachalam S.C., Gao L. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 2003, 424(6944):94-98.